ArticleFrontiers in immunology2025
A novel nomogram for survival prediction in renal cell carcinoma patients with brain metastases: an analysis of the SEER database.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Analysis of risk factors and development of a predictive model for new vertebral fractures subsequent to percutaneous kyphoplasty in patients with single-segment osteoporotic vertebral compression fractures.BMC musculoskeletal disorders · 2026Article
- A novel prognostic nomogram for elderly renal cell carcinoma patients with lung metastases.Scientific reports · 2026Article
- Machine learning prediction of overall survival in patients with cT1b renal cell carcinoma after surgical resection using the SEER database.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Existing research on the development of prognostic models for renal cell carcinoma (RCC) patients with brain metastases (BM) remains limited. This study aimed to develop a prognostic prediction model for RCC patients with BM and to identify critical factors influencing clinical outcomes. Methods: Patients diagnosed with BM between 2010 and 2019 were identified and extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Potential risk factors were initially screened applying the eXtreme Gradient Boosting (XGBoost) and Random Forest (RF) machine learning algorithms. Subsequently, multivariate COX regression analysis was performed to identify independent risk factors for constructing the predictive nomogram. Nomogram performance was comprehensively evaluated based on Harrell's concordance index (C-index), receiver operating characteristic (ROC) curve analysis, calibration plots, and decision curve analysis (DCA). The SHapley Additive exPlanations (SHAP) method was employed to demonstrate the ranking of feature importance affecting patient prognosis at different time points. Moreover, we conducted propensity score matching (PSM) and Kaplan-Meier (K-M) survival analysis to compare clinical outcomes between surgical and non-surgical treatment subgroups. Results: In total, 982 patients were assigned to the training cohort and 420 to the validation cohort. The constructed nomogram included four clinical variables: histologic type, T stage, N stage, surgery and chemotherapy. The AUC, C-index, calibration curves, and DCA curves showed excellent performance of the nomogram. In addition, the SHAP values indicated that surgical treatment was the most important prognostic risk factor for OS at 6-months, 1-year, 2-years, and 3-years. After further balancing the baseline characteristics between the surgical and non-surgical groups using PSM, we observed that patients with BM who underwent surgical intervention showed significantly better survival outcomes across all subgroups compared to non-surgical patients, though unmeasured confounders may contribute to this association. Conclusion: We developed a novel nomogram for predicting prognostic factors in RCC patients with BM, offering a valuable tool to support accurate clinical decision-making. Our research also confirmed that surgical intervention was significantly associated with improved survival outcomes for patients with BM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.